Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $49.4M
Liabilities Breakdown FY2019
Total Liabilities: $17.7M
Asset Breakdown
Total Assets: $49.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.4M | 75.7% |
| Accounts Receivable | $2.0M | 4.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.9M | 3.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.1M | 16.5% |
Liabilities Breakdown
Total Liabilities: $17.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 18.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $14.5M | 82.0% |